CHIBA, Japan--(BUSINESS WIRE)--Transparent Inc., a bio-venture business headquartered here, announced today that it will host a session presenting the most recent results validating Cell-able (http://www.cell-able.com ), a human hepatocyte array kit with the potential to reduce drug development costs and time-to-market for pharmaceutical companies, to attendees of the annual meeting of the Society of Toxicology, in Salt Lake City on March 9 at 9:45 a.m. (http://toxicology.org/AI/MEET/AM2010/exhibit_hostsess.asp ).
